Cite
APA Citation
Chaplin, S., & Wilding, J. (n.d.). dapagliflozin: first SGLT2 inhibitor for type 2 diabetes. Prescriber, 24(12), 13–16. http://access.bl.uk/ark:/81055/vdc_100024916060.0x00002c
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chaplin, S., & Wilding, J. (n.d.). dapagliflozin: first SGLT2 inhibitor for type 2 diabetes. Prescriber, 24(12), 13–16. http://access.bl.uk/ark:/81055/vdc_100024916060.0x00002c